Phase 2 protocol submitted to HREC to evaluate tivoxavir marboxil (TXM) in a combined seasonal and bird flu study in the Southern Hemisphere Briefing documents submitted to FDA for a Type D meeting ...

New research from the University of Pittsburgh School of Medicine and La Jolla Institute for Immunology, published today in ...

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

The company announced that the US FDA has expanded the approved use of its oral antiviral drug Mavyret, developed in ...

An interdisciplinary research team involving the German Center for Infection Research (DZIF) has identified two antiviral ...

Adam Kovalčík, age 19, innovated a cheaper, faster way to produce an antiviral drug. Galidesivir targets RNA viruses like COVID-19, Ebola, and Zika but hasn't completed clinical trials ...

If more people at higher risk for severe illness get treatment in a timely manner, we will save lives." Antiviral drugs, such as Tamiflu or generic oseltamivir phosphate, are prescription medicines ...

Antiviral drugs work best when taken within 48 hours of onset of flu symptoms, but they may still offer benefits when taken later. These medications may reduce the duration of flu by one to two ...

How Herpes’ DNA Polymerase Helps Virus Evade Antiviral Drugs August 28, 2024. Herpes virus [photoman / 1173676633 / iStock / Getty Images Plus] A common ...

A new “dual mutant" strain of H1N1 influenza could pose a threat in the U.S., according to the Centers for Disease Control and Prevention. Dr. Marc Siegel offered input on the potential risks.

NanoViricides, Inc., a clinical-stage global leader in broad-spectrum antiviral nanomedicines, elaborates on its development of a first-in-class, broad-spectrum antiviral agent that could ...